PRSS58: A Potential Cancer Drug Target and Biomarker (G136541)

Target Name: PRSS58

NCBI ID: G136541

PRSS58

PRSS58: A Potential Cancer Drug Target and Biomarker

PRSS58 (TRYX3) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidney. It is a key regulator of cell proliferation and has been implicated in a number of diseases, including cancer.

One of the key functions of PRSS58 is its role in cell signaling. It is a transcription factor that can bind to DNA and regulate gene expression. This function is critical for the development and maintenance of tissues and organs, and is also important for the regulation of cancer growth.

In addition to its role in cell signaling, PRSS58 is also involved in the regulation of cellular processes that are critical for tissue growth and development. It is a regulator of cell adhesion, which is the process by which cells stick together to form tissues and organs . It also plays a role in the regulation of cell migration, which is the movement of cells from one location to another in the body.

PRSS58 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of cancer. It has been shown to promote the growth and survival of cancer cells, and to contribute to the development of cancer-induced submit.

The discovery of PRSS58 as a potential drug target or biomarker has significant implications for the treatment of cancer. PRSS58 has been shown to be involved in the development and progression of many types of cancer, including breast, lung, and ovarian cancer. Therefore, targeting PRSS58 with drugs or other therapeutic agents may be an effective way to treat these cancers.

In addition to its potential as a cancer drug target, PRSS58 may also be used as a biomarker for the diagnosis and monitoring of cancer. Its expression has been shown to be elevated in the blood and other body fluids of individuals with cancer, and it has has been used as a biomarker in a number of cancer clinical trials.

The identification of PRSS58 as a potential drug target or biomarker has also led to a greater understanding of the underlying mechanisms of cancer. PRSS58 is involved in the regulation of a wide range of cellular processes, and its role in these processes may be important for the development and progression of cancer.

In conclusion, PRSS58 is a protein that is expressed in various tissues of the body and is involved in the regulation of cell signaling and cellular processes that are critical for tissue growth and development. Its potential as a cancer drug target or biomarker has significant implications for the treatment of cancer. Further research is needed to fully understand its role in these processes and to develop effective therapies for the treatment of cancer.

Protein Name: Serine Protease 58

The "PRSS58 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRSS58 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets